Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02296528 · ClinicalTrials.gov registry record · NA
Safety and Efficacy of the Swallow Expansion Device (SED) for Improvement of Swallowing in Patients
A NA study, sponsored by Peter Belafsky, MD.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT02296528 is a NA study that was terminated before completion, run by Peter Belafsky, MD. The registered enrollment target is 4 participants.
The verdict
NCT02296528, a NA study, was terminated before completion, sponsored by Peter Belafsky, MD.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
Biomedical devices, such as artificial joints and pacemakers, are accepted and commonly used in medicine. While great progress in biomedical devices has been made for many other disorders, there is currently no device available to assist with the act of deglutition. The investigators have developed a biomedical device (Swallow Expansion Device, SED) that assists with swallowing by mechanically opening the upper esophageal sphincter and allowing food and liquid to safely enter the esophagus. The SED has proven safe in cadaver and live animal studies (Belafsky, 2010).
Interventions
- DEVICE Swallowing Expansion Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2014-06 |
| Est. Completion | 2022-10-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02296528
The ClinicalTrials.gov registry entry for NCT02296528 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Peter Belafsky, MD, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Swallowing Expansion Device is the first listed.
NCT02296528 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02296528 about?
NCT02296528 is a clinical study titled "Safety and Efficacy of the Swallow Expansion Device (SED) for Improvement of Swallowing in Patients". Biomedical devices, such as artificial joints and pacemakers, are accepted and commonly used in medicine. While great progress in biomedical devices has been made for many other disorders, there is currently no device available to assist with the act of deglutition. The investigators have developed ...
What is the current status of trial NCT02296528?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2014-06. Estimated completion is 2022-10-17.
What interventions are being tested in trial NCT02296528?
The interventions under investigation include: Swallowing Expansion Device (DEVICE).
Who is sponsoring clinical trial NCT02296528?
This trial is sponsored by Peter Belafsky, MD, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.